Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1

Interventions

Rituximab 1372 Cyclophosphamide 1299 Vincristine 664 Doxorubicin 585 Etoposide 525 Prednisone 506 Cytarabine 482 fludarabine 462 Methotrexate 442 Dexamethasone 412 fludarabine phosphate 396 Lenalidomide 347 Filgrastim 342 Bendamustine Hydrochloride 275 Radiotherapy 266 venetoclax 255 ibrutinib 249 Peripheral Blood Stem Cell Transplantation 233 Melphalan 229 obinutuzumab 228 Granulocyte Colony-Stimulating Factor 212 Bortezomib 204 Gemcitabine 201 Busulfan 186 Whole-Body Irradiation 185 Mycophenolic Acid 174 Tacrolimus 164 Specimen Handling 163 Magnetic Resonance Spectroscopy 151 Calcium Dobesilate 151

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Flavin-Adenine Dinucleotide × Lymphoid × Clear all

NCT00840385 2010-09-15

FAD

Fudan University

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡